![]() |
![]() |
|
=> nom de la substance active, DJA, ARfD, AOEL, PNEC, classement
- lien vers la fiche d'information
qui contient le détail des données présentées dans le tableau
- les définitions des données présentées sont disponibles dans le guide
| Substance | DJA (mg/kg/j) | ARfD (mg/kg/j) | AOEL (mg/kg/j) | PNEC (µg/L) | Classement |
| 1-methylcyclopropene | 0.0009 | 0.07 | 0.009 | 7.76 | N R50/53 |
| 2,4-D | 0.05 | non pertinent | 0.15 | 58 | N Xn R22 R37 R41 R43 R52/53 |
| 2,4-D ethylhexyl ester | se reporter au 2,4-D acide | non pertinent | se reporter au 2,4-D acide | 12 | N Xn R22 R43 R50/53 S2 S36/37 S46 S60 S61 |
| 2,4-DB | 0.02 | non pertinent | 0.08 | 30 | N Xn R22 R51/53 |
| 2,5-dichlorobenzoic acid methylester (fiche en cours d'élaboration) | non fixée par l 'UE car non pertinent d'apres l'usage (19/12/2008) | non fixée par l 'UE car non pertinent d'apres l'usage (19/12/2008) | 0.1 | ||
| 6-benzyladenine | 1.1 | 0.6 | 31 | N Xn R22 R41 R50/53 | |
| 8-dodecenylacetate | EC | ||||
| abamectine | 0.0025 | 0.005 | 0.0025 | 0.0163 | N T+ R28 R50/53 |
| acetamiprid | 0.07 | 0.1 | 0.124 | 0.5 | Xn R22 R52/53 S2 S46 S61 |
| acetates de Z/E 8-dodecenyl et de Z 8-dodecenol | EC | ||||
| acetochlore | 0.011 | 1.5 | 0.02 | 0.35 | N Xn R20 R37/38 R43 R50/53 S2 S36/37 S60 S61 |
| acibenzolar S methyl | 0.1 | non pertinent | 0.1 | 4 | N Xi R36/37/38 R43 R50/53 S2 S24/25 S37 S46 S59 S60 S61 |
| acide benzoique | 5 | non pertinent. | 5 | 550 | Xi R41 |
| acide indolyl butyrique | |||||
| acide naphtalene acetique | |||||
| acide pelargonique (fiche en cours d'élaboration) | 41 | ||||
| acide phosphoreux (fiche en cours d'élaboration) | 10000 | ||||
| aclonifen | 0.016 | non pertinenten accord avecUE 01/09/2008 (réglement LMR 396/2005), | 0.07 | 0.5 | N R50/53 |
| acrinathrine | 0.001 | 0.01 | N Xn R20 R50/53 | ||
| alpha naphtalene acetamide | |||||
| alphamethrine | 0.015 | 0.04 | 0.01 | 0.015 | N T R25 R37 R48/22 R50/53 S1/2 S36/37/39 S45 S60 S61 |
| amidosulfuron | 0.2 | 1.4 | EC | ||
| aminotriazole | 0.001 | non pertinent | 0.001 | 32 | N Xn R48/22 R51/53 R63 S13 S2 S36/37 S61 |
| amitraze (fiche en cours d'élaboration) | 0.01 | 0.01 | 0.35 | N Xn R22 R43 R48/22 R50/53 S2 S22 S24 S36/37 S60 S61 | |
| asulame : sel sodique | 0.35 | 1 | |||
| azimsulfuron | 0.1 | non pertinent | 0.2 | 0.08 | N R50/53 S60 S61 |
| azinphos-methyl | 0.005 | 0.01 | 0.005 | N T+ R24 R26/28 R43 R50/53 | |
| azoxystrobine | 0.1 | non pertinent | 0.1 | 1.5 | N T R23 R50/53 S1/2 S22 S45 S60 S61 |
| beflubutamid (fiche en cours d'élaboration) | 0.445 | N R50/53 S60 S61 | |||
| benalaxyl | 0.04 | non pertinent, à appliquer à benalaxyl-M | 0.06 | 3 | N R50/53 S60 S61 |
| benfluraline | 0.005 | non pertinent d'après l l'UE 01/09/2008 et le réglement 396/2005 | 0.05 | EC | |
| benfuracarbe | 0.01 | 0.02 | 0.01 | N T R22 R23 R50/53 R62 S1/2 S36/37 S45 S60 S61 | |
| benoxacor | 0.004 | 0.05 | 1.6 | N Xi R43 R50/53 S2 S36/37 S46 S60 S61 | |
| bensulfuron-methyle | 0.2 | N Xi R43 R51/53 | |||
| bentazone | 0.1 | 0.25 | 0.13 | 540 | Xn R22 R36 R43 R52/53 S2 S24 S37 S61 |
| benthiavalicarb-isopropyl | 0.1 | 0.1 | 0.1 | 100 | Xn R40 R43 R52/53 S24 S37 |
| betacyflutrine | 0.003 | 0.02 | 0.02 | 0.00068 | N T+ R26/28 R50/53 |
| bifenazate | 0.01 | non pertinent | 0.0028 | 0.4 | N Xi R43 R50/53 S36/37 S60 S61 |
| bifenox | 0.3 | 0.5 | 0.125 | 1.3 | EC |
| bifenthrine | 0.015 | 0.03 | 0.0075 | 0.001 | N T R20 R25 R40 R43 R50/53 S36/37 S45 S60 S61 |
| bitertanol | 0.01 | 2.4 | Xn R48/22 | ||
| boscalid | 0.04 | non pertinent | 0.1 | 12.5 | N R51/53 S60 S61 |
| bromadiolone | T+ R26/27/28 R52/53 | ||||
| bromoxynil heptanoate | se reporter au bromoxynil phénol | se reporter au bromoxynil phénol | se reporter au bromoxynil phénol | 0.29 | N Xn R20/22 R43 R50/53 R63 S2 S36/37 S46 S60 S61 |
| bromoxynil octanoate | se reporter au bromoxynil phénol | se reporter au bromoxynil phénol | se reporter au bromoxynil phénol | 0.41 | N T R22 R23 R43 R50/53 R63 S1/2 S36/37 S45 S60 S61 S63 |
| bromoxynil phenol | 0.01 | 0.04 | 0.01 | 3.3 | N T+ R25 R26 R43 R50/53 R63 S1/2 S27/28 S36/37 S45 S60 S61 S63 |
| bromuconazole | 0.01 | 1.25 | 0.025 | N Xn R22 R50/53 | |
| bupirimate | 0.05 | non pertinente,UE 01/09/2008 (réglement 396/2005), d'après la monographie hollandaise | EC | ||
| buprofezine (fiche en cours d'élaboration) | 0.01 | 0.5 | EC | ||
| cadusafos (fiche en cours d'élaboration) | 0.0004 | 0.003 | 0.0007 | N T+ R25 R26/27 R50/53 FAUNE SAUVAGE | |
| captane | 0.1 | 0.3 | 0.1 | 9.8 | N T R23 R40 R41 R43 R50 S1/2 S26 S29 S36/37/39 S45 S61 |
| carbendazime | 0.02 | 0.02 | 0.02 | 0.15 | N T R46 R50/53 R60 R61 S45 S53 S60 S61 |
| carbetamide | 0.02 | 0.05 | 0.03 | 34 | Xn R22 R40 R52/53 R63 S2 S36/37 S46 |
| carbofuran | 0.001 | 0.001 | 0.001 | N T+ R26/28 R50/53 | |
| carbosulfan | 0.01 | 0.01 | 0.02 | N T+ R25 R26 R43 R50/53 S1/2 S28 S36/37 S38 S45 S60 S61 S63 | |
| carboxine | 0.0016 | 0.055 | EC | ||
| carfentrazone ethyle | 0.03 | non pertinent | 0.6 | 0.57 | N R50/53 S60 S61 |
| chlorantraniliprole (fiche en cours d'élaboration) | |||||
| chloridazone | 0.1 | non pertinent d'apresevaluation EFSA etUE 01/09/2008 (réglement 396/2005) | 0.2 | 1.8 | N Xi R43 R50/53 |
| chlormequat | 0.04 | 0.09 | 0.04 | Xn R21/22 S46 | |
| chloropicrine | 5e-005 | 5e-005 | AOEL inhalation : 0.03 ppm (0.22 mg/m3). | 0.011 | T+ R22 R26 R36/37/38 |
| chlorothalonil | 0.015 | 0.6 | 0.009 | 1 | N T+ R26 R37 R40 R41 R43 R50/53 S1/2 S28 S36/37/39 S45 S60 S61 |
| chlorprophame | 0.05 | 0.5 | 0.05 | 32 | N Xn R40 R48/22 R51/53 S2 S36/37 S61 |
| chlorpyriphos-ethyl | 0.01 | 0.1 | 0.01 | 0.1 | N T R25 R50/53 S1/2 S45 S60 S61 |
| chlorpyriphos-methyl | 0.01 | 0.1 | 0.01 | N Xi R43 R50/53 S2 S36/37 S60 S61 | |
| chlorsulfuron | 0.05 | non pertinent, UE 01/09/2008 (réglement 396/2005) | 0.43 | N R50/53 | |
| chlortoluron | 0.04 | non pertinent, UE 01/09/2008 (réglement 396/2005) | 0.215 | 2.4 | N Xn R40 R50/53 R63 S2 S26 S36/37 S46 S60 S61 |
| chlorure de didecyl dimethyl ammonium (fiche en cours d'élaboration) | 0.005 | 0.005 | 0.005 | ||
| cinidon-ethyl | 0.01 | non pertinent | 0.02 | N Xn R40 R43 R50/53 S2 S24 S37 S46 S60 S61 | |
| clethodim | 0.16 | non pertinent UE 01/09/2008 (réglement 396/2005), praper 34 | 0.25 | Xn R20/22 R36/38 R52/53 S2 S36/37 S46 | |
| clodinafop-propargyl | 0.003 | 0.05 | 0.026 | 2.1 | N Xn R22 R43 R48/22 R50/53 S2 S24 S36/37 S46 S60 S61 |
| clofentezine | 0.02 | EC | |||
| clomazone | 0.133 | non pertinente | 0.133 | 5.7 | Xn R20/22 |
| clopyralid | 0.15 | non pertinent | 1 | 1080 | Xi R41 S2 S26 S39 |
| cloquintocet-mexyl | 0.04 | 63 | N Xn R48/22 R50/53 | ||
| clothianidine (fiche en cours d'élaboration) | 0.097 | 0.1 | 0.1 | 0.5 | N Xn R22 R50/53 S2 S46 S60 S61 |
| codlemone (fiche en cours d'élaboration) | N Xi R38 R50/53 | ||||
| cuivre de l'hydroxyde de cuivre | 0.15 | non pertinent d'après la monographie française | 0.072 | 4 | N T R22 R23 R41 R50/53 S1/2 S24 S26 S37 S39 S45 S60 S61 |
| cuivre de l'oxychlorure de cuivre | 0.15 | non pertinent d'après la monographie française | 0.072 | 4 | N Xn R20 R22 R50/53 S2 S24 S37 S46 S60 S61 |
| cuivre de l'oxyde cuivreux | 0.15 | non pertinent d'après la monographie française | 0.072 | 12 | N Xn R20 R22 R50/53 S2 S46 S60 S61 |
| cuivre de la bouillie bordelaise | 0.15 | non pertinent d'après la monographie française | 0.072 | 4 | N Xn R20 R41 R50/53 S2 S26 S39 S46 S60 S61 |
| cuivre du sulfate tribasique de cuivre | 0.15 | non pertinent d'après la monographie française | 0.072 | 4 | N Xn R22 R50/53 S2 S46 S60 S61 |
| cyazofamid | 0.17 | non pertinent | 0.3 | 1.9 | N R50/53 S60 S61 |
| cycloxidime | 0.032 | 1 | 0.22 | 3200 | EC |
| cyflufenamide (fiche en cours d'élaboration) | 0.04 | 0.05 | 0.03 | 2.4 | EC |
| cyfluthrine | 0.003 | 0.02 | 0.02 | 0.01 | N T+ R23 R28 R50/53 S1/2 S28 S36/37/39 S45 S60 S61 |
| cyhalofop butyl | 0.003 | non pertinent | 0.03 | 6.37 | N Xi R36 R50/53 S46 S60 S61 |
| cymoxanil | 0.013 | 0.08 | 0.01 | 4.4 | N Xn R22 R43 R50/53 S2 S36/37 S60 S61 |
| cypermethrine | 0.05 | 0.2 | 0.06 | 0.01 | N Xn R20/22 R37 R50/53 S2 S24 S36/37/39 S60 S61 |
| cypermethrine high cis | N Xn R22 R37/38 R43 R50/53 S2 S36/37/39 S60 S61 | ||||
| cyproconazole | 0.02 | 0.02 | 0.02 | 2.8 | N Xn R22 R50/53 R63 S2 S36/37 S60 S61 |
| cyprodinil | 0.03 | non pertinent, | 0.03 | 6.5 | N Xi R43 R50/53 S2 S24 S37 S46 S60 S61 |
| cyromazine | 0.17 | EC | |||
| daminozide | 0.45 | non pertinent (usage horticulture). | 0.16 | Xn R40 | |
| dazomet | 0.004 | 0.03 | N Xn R22 R36 R50/53 | ||
| deltamethrine | 0.01 | 0.01 | 0.0075 | 0.0105 | N T R23/25 R50/53 S1/2 S24 S28 S36/37/39 S38 S45 S60 S61 |
| desmediphame | 0.03 | 0.1 | 0.04 | 1 | N R50/53 S60 S61 |
| desthioprothioconazole (fiche en cours d'élaboration) | 0.01 | 0.01 | 0.01 | N T R50/53 R61 S2 S36/37 S46 | |
| dicamba | 0.3 | 0.3 | 0.3 | 180 | Xn R22 R41 R52/53 |
| dichlormide | 0.01 | 0.05 | Xi R38 R43 R52/53 | ||
| dichlorprop P | 0.06 | 0.5 | 0.35 | 9.1 | N Xn R22 R38 R41 R43 S2 S24 S26 S37/39 |
| diclofop methyl | 0.002 | 0.03 | 0.0015 | 1.5 | N Xn R22 R43 R50/53 |
| diethofencarbe | 0.4 | 3 | Xn R40 | ||
| difenacoum | non pertinente d'après les usages envisagés (EFSA et reglement LMR) | non pertinente d'après les usages envisagés (EFSA et reglement LMR) | 2e-005 | N T+ R28 R48/25 R50/53 | |
| difenoconazole | 0.01 | 0.2 | 0.2 | 0.56 | Xn R22 R48/22 |
| diflubenzuron | 0.012 | non pertinent | 0.0066 | 0.07 | EC |
| diflufenican | 0.2 | non pertinente | 0.11 | 0.025 | EC R52/53 S61 |
| dimethachlore | 0.1 | 0.5 | 0.1 | 0.217 | N Xn R22 R43 R50/53 |
| dimethenamid P | 0.02 | 0.25 | 0.04 | 0.89 | N Xn R22 R43 R50/53 S36/37 S46 S60 S61 |
| dimethoate | 0.001 | 0.01 | 0.001 | Xn R21/22 | |
| dimethomorphe | 0.05 | 0.6 | 0.15 | N R51/53 | |
| dimoxystrobine | 0.004 | 0.004 | 0.02 | 0.032 | N Xn R20 R40 R50/53 R63 S2 S36/37 S46 S60 S61 |
| diquat dibromure | 0.002 | non pertinent | 0.001 | 1 | N T+ R22 R26 R36/37/38 R43 R48/25 R50/53 S1/2 S28 S36/37/39 S45 S60 S61 |
| disodium phosphanate (fiche en cours d'élaboration) | 3 | non pertinent | 3 | 729 | EC |
| dithianon | 0.01 | 0.12 | 0.12 | N Xn R22 R50/53 | |
| diuron (fiche en cours d'élaboration) | 0.007 | 0.016 | 0.007 | 0.52 | N Xn R22 R40 R48/22 R50/53 S13 S2 S36/37 S46 S60 S61 |
| dodemorphe acetate | 0.1 | 0.4 | 0.04 | N Xi R36 R37 R38 R51 R53 | |
| doguadine | 0.1 | non pertinent, UE 01/09/2008 (réglement 396/2005) | 0.15 | 0.44 | N Xn R22 R36/38 R50/53 |
| epoxiconazole | 0.008 | 0.023 | 0.008 | 0.81 | N Xn R40 R51/53 R62 R63 S2 S36/37 S46 S61 |
| esfenvalerate | 0.02 | 0.05 | 0.018 | 0.08 | N T R23/25 R43 R50/53 S1/2 S24 S36/37/39 S45 S60 S61 |
| ethephon | 0.03 | 0.05 | 0.03 | C R20/21 R34 R52/53 S1/2 S26 S28 S36/37/39 S45 S60 S61 | |
| ethofumesate | 0.07 | nonpertinent,UE 01/09/2008 (réglement 396/2005) | 2.5 | 32 | N R51/53 S61 |
| ethoprophos | 0.0004 | 0.01 | 0.001 | 0.2 | N T+ R25 R26/27 R43 R50/53 S1/2 S27/28 S36/37/39 S45 S60 S61 |
| ethoxyquine | 0.005 | 0.5 | Xn R22 | ||
| éthylènethiourée (ETU) (fiche en cours d'élaboration) | 0.002 | 0.05 | 0.004 | T R22 R61 | |
| etofenprox | 0.03 | 1 | 0.06 | 0.0054 | N R50/53 |
| etoxazole | 0.04 | non pertinent. | 0.03 | 0.28 | N R50/53 S60 S61 |
| famoxadone | 0.012 | 0.2 | 0.0048 | 0.8 | N Xn R48/22 R50/53 S2 S46 S60 S61 |
| FEN 560 (extrait de fenugrec) | 25 | non pertinent d'apres la CT octobre 2004 et les end points finalisés UE octobre 2007. | 25 | 1000 | EC |
| fenamidone | 0.03 | non pertinent | 0.3 | 0.55 | N R50/53 S60 S61 |
| fenarimol (fiche en cours d'élaboration) | 0.01 | 0.02 | 0.02 | N Xn R51/53 R62 R63 R64 | |
| fenazaquin | 0.005 | 0.05 | N T R20 R25 R48/22 R50/53 R57 | ||
| fenbuconazole | 0.006 | 0.3 | 0.03 | 6.8 | N Xn R48/22 R50/53 S60 S61 |
| fenbutatin oxyde | 0.03 | non pertinent d'apres les EPCO. | 0.8 | 0.104 | N T+ R26 R36/38 R50/53 |
| fenclorim | 0.05 | Xi R43 | |||
| fenhexamid | 0.2 | non pertinent | 0.3 | 10.1 | N R51/53 S61 |
| fenitrothion (fiche en cours d'élaboration) | 0.005 | 0.013 | 0.013 | N Xn R22 R50/53 | |
| fenoxaprop-P-ethyl | 0.01 | non pertinent, d'après le réglement 396/2005 (UE 01/09/2008) | 0.014 | 1 | Xi R43 S2 S36/37 S46 |
| fenoxycarbe | 0.06 | non pertinente, UE 01/09/2008 (réglement 396/2005) | 0.04 | N R50/53 | |
| fenpropidine | 0.02 | 0.02 | 0.02 | 0.12 | N Xn R22 R36 R43 R50/53 S2 S36/37 S46 |
| fenpropimorphe | 0.003 | 0.2 | 0.007 | 0.016 | N Xn R22 R38 R51/53 R63 S2 S36/37 S46 S61 |
| fenpyroximate | 0.01 | 0.02 | 0.005 | N T R22 R23 R43 R50/53 | |
| fipronil | 0.0002 | 0.009 | 0.0035 | 0.00077 | N T R23/24/25 R48/25 R50/53 S1/2 S28 S36/37 S45 S60 S61 |
| flazasulfuron | 0.013 | non pertinent | 0.02 | 0.07 | N R50/53 |
| flonicamid | 0.025 | 0.025 | 0.025 | 310 | Xn R22 S2 S46 |
| florasulam | 0.05 | non pertinent | 0.05 | 0.118 | N R50/53 S60 S61 |
| florchlorfenuron (fiche en cours d'élaboration) | 0.05 | 1 | 0.25 | 88 | |
| fluazifop P butyl | 0.01 | 0.02 | 0.02 | 5.3 | N Xn R50/53 R63 S2 S29 S36/37 S46 S60 S61 |
| fluazinam | 0.01 | 0.07 | 0.004 | 1.1 | N T R23 R36 R48/22 R50/53 R63 |
| fludioxonyl | 0.37 | non pertinent, en accord avec le réglement 396/2005 (UE 01/09/2008) (EFSA 2007) | 0.59 | 3.28 | N R50/53 S60 S61 |
| flufenacet | 0.005 | 0.017 | 0.017 | 0.2 | N Xn R22 R43 R48/22 R50/53 S13 S2 S24 S37 S60 S61 |
| flufenoxuron | 0.0035 | 0.49 | 0.0045 | ||
| flumioxazine | 0.009 | 0.05 | 0.018 | 0.23 | N T R50/53 R61 S45 S53 S60 S61 |
| fluopicolide | 0.08 | 0.18 | 0.05 | 2.9 | EC R50/53 |
| fluorure de sulfuryle | 0.014 | 0.7 | 2 | 6.2 | T R23 R48/20 R50 S1/2 S45 S60 S61 S63 |
| fluoxastrobine | 0.015 | 0.3 | 0.03 | 0.061 | N Xn R40 R50/53 |
| flupyrsulfuron methyle | 0.035 | non pertinent | 0.08 | 0.25 | N R50/53 S60 S61 |
| fluquinconazole | 0.002 | 0.02 | 0.07 | N T R21 R23/25 R38 R48/25 R50/53 S1/2 S36/37/39 S38 S45 S60 S61 | |
| flurochloridone | 0.02 | 0.025 | Xn R62 | ||
| fluroxypyr | 0.8 | non pertinent | 0.8 | 143 | EC R52/53 S61 |
| fluroxypyr : methylheptyl ester | se reporter au fluroxypyr acide. | se reporter au fluroxypyr acide. | se reporter au fluroxypyr acide. | 3.7 | N R50/53 S60 S61 |
| flurprimidol | 0.014 | Xn R22 R52/53 | |||
| flurtamone | 0.03 | non pertinent | 0.02 | 0.99 | N R50/53 |
| flusilazole | 0.002 | 0.005 | 0.005 | 1 | N T R22 R40 R51/53 R61 S45 S53 S61 |
| flutolanil | 0.09 | non pertinent, UE 01/09/2008 (réglement 396/2005) | 0.56 | 22 | N R51/53 |
| flutriafol | 0.01 | 0.05 | Xn R22 R48/22 | ||
| folpel | 0.1 | 0.2 | 0.1 | 1.96 | N Xn R20 R36 R40 R43 R50 S2 S36/37 S46 S61 |
| foramsulfuron | 0.5 | non pertinent | 0.1 | 0.065 | N R50/53 |
| formetanate | 0.004 | 0.005 | 0.004 | N T+ R26/28 R43 R50/53 | |
| fosetyl-al | 3 | non pertinent,UE 01/09/2008 (réglement 396/2005) | 5 | 296 | Xi R41 S2 S26 S39 S46 |
| fosthiazate | 0.004 | 0.005 | 0.005 | 2.82 | N T R21 R23/25 R39 R41 R43 R50/53 |
| gamma cyhalothrine (fiche en cours d'élaboration) | |||||
| gibberelline A4 A7 | 54 | ||||
| glufosinate ammonium | 0.021 | 0.021 | 0.0021 | T R20/21/22 R48/20/22 R60 R63 S45 S53 | |
| glyphosate | 0.3 | non pertinent | 0.2 | 60 | N Xi R41 R51/53 S2 S26 S39 S61 |
| guazatine triacetate | 0.025 | 0.056 | 0.002 | N T+ R21/22 R26 R37/38 R41 R50/53 S1/2 S26 S28 S36/37/39 S38 S45 S46 S60 S61 S63 | |
| haloxyfop-R : ester methylique | 0.00065 | 0.075 | N Xn R22 R48/22 R50 R53 | ||
| hexythiazox | 0.03 | non pertinent (monographie Finlande) | N R50/53 | ||
| huile de girofle (fiche en cours d'élaboration) | |||||
| huile essentielle d'orange douce (fiche en cours d'élaboration) | 1 | N Xi R36/38 R43 S24 S37 | |||
| hydrazide maleique | 0.25 | non pertinent | 0.25 | 57 | EC |
| hymexazol | 0.2 | 1.5 | Xn R22 R41 R52/53 | ||
| imazalil | 0.025 | 0.05 | 0.05 | 14.8 | N Xn R20/22 R41 R50/53 S2 S26 S39 S46 S60 S61 |
| imazamox | 9 | non pertinent | 14 | 1.1 | N R50/53 S60 S61 |
| imazaquine | 0.25 | non pertinent d'apres la monographie belge | EC | ||
| imidaclopride | 0.06 | 0.08 | 0.08 | 4.7 | N Xn R22 R50/53 S2 S22 S57 S60 S61 |
| indoxacarbe | 0.006 | 0.125 | 0.004 | 2.6 | Xn R22 R43 R50 |
| iodosulfuron | 0.03 | non pertinent | 0.05 | 0.054 | N R50/53 S60 S61 |
| ioxynil octanoate | se reporter au ioxynil phénol | se reporter au ioxynil phénol | se reporter au ioxynil phénol | 1.1 | N T R25 R36 R43 R50/53 R63 S1/2 S26 S36/37 S45 S60 S61 |
| ioxynil phenol | 0.005 | 0.04 | 0.01 | 1.3 | N T R21 R23/25 R36 R48/22 R50/53 R63 S1/2 S36/37 S45 S60 S61 S63 |
| iprodione | 0.06 | non pertinent | 0.3 | 5.5 | N Xn R40 R50/53 |
| iprovalicarbe | 0.015 | non pertinent | 0.015 | 189 | EC |
| isoproturon | 0.015 | non pertinent | 0.015 | 1.3 | N Xn R40 R50/53 S2 S36/37 S60 S61 |
| isoxaben | 0.06 | non pertinent, | 0.94 | 1.1 | EC |
| isoxadifen ethyl | 0.033 | 0.021 | N Xn R22 R43 R50/53 | ||
| isoxaflutole | 0.02 | non pertinent | 0.02 | 0.32 | N Xn R50/53 R63 |
| kaolin | 143 | 10.7 | 1700 | EC | |
| kresoxim methyl | 0.4 | non pertinent | 0.9 | 15 | N Xn R40 R50/53 S2 S36/37 S46 S60 S61 |
| lambda cyhalothrine | 0.005 | 0.0075 | 0.0025 | 0.00016 | N T+ R21 R25 R26 R50/53 S1/2 S28 S36/37/39 S38 S45 S60 S61 |
| laminarine | non pertinente compte tenu de la nature de la substance (décision UE,8/10/2004). | non pertinente compte tenu de la nature de la substance (décision UE, 8/10/2004). | 1000 | EC | |
| lenacile | 0.14 | non pertinent | 0.16 | 0.77 | EC |
| linuron | 0.003 | 0.03 | 0.009 | 2.1 | N T R22 R40 R48/22 R50/53 R61 R62 S45 S53 S60 S61 |
| lufenuron | 0.015 | non pertinent, d'après EFSA et UE 01/09/2008 (réglement 396/2005) | 0.01 | 0.013 | N Xi R43 R50 R53 |
| mancozebe | 0.05 | 0.6 | 0.035 | 7.3 | N Xn R43 R50 R63 S2 S36/37 S46 S61 |
| mandipropamide | 0.03 | non pertinente | 0.035 | 9.7 | EC |
| manebe | 0.05 | 0.2 | 0.03 | 7 | N Xn R20 R36 R43 R50/53 R63 S2 S36/37 S46 S60 S61 |
| MCPA | 0.05 | 0.15 | 0.04 | 15.2 | N Xn R22 R38 R41 R50/53 S2 S26 S37 S39 S60 S61 |
| MCPB | 0.01 | 0.05 | 0.06 | 43 | N R50/53 S60 S61 |
| mecoprop | 0.01 | non pertinent | 0.04 | 2200 | N Xn R22 R38 R41 R50/53 S13 S2 S26 S37/39 S60 S61 |
| mecoprop-P | 0.01 | non pertinent | 0.04 | 160 | N Xn R22 R41 R51/53 S13 S2 S26 S37/39 S46 S61 |
| mefenpyr diethyl | 0.5 | 0.42 | 10 | N R51/53 S60 S61 | |
| mepanipyrim | 0.02 | 0.3 | 0.07 | 1.8 | N Xn R40 R50/53 S2 S36/37 S46 S60 S61 |
| mepiquat-chlorure | 0.3 | 0.6 | 0.3 | Xn R22 R52/53 | |
| meptyldinocap | 0.016 | 0.011 | 0.041 | Xi R43 | |
| mercaptodimethur | 0.013 | 0.013 | 0.013 | N T R25 R50/53 S45 S60 S61 | |
| mesosulfuron methyl | 1 | non pertinent | 0.2 | 0.062 | N R50/53 S60 S61 |
| mesotrione | 0.01 | 0.02 | 0.015 | 0.77 | N R50/53 S60 S61 |
| metalaxyl (fiche en cours d'élaboration) | 0.03 | Xn R22 R43 R52/53 S13 S2 S24 S37 S46 S61 | |||
| metalaxyl-M | 0.08 | 0.5 | 0.08 | 120 | Xn R22 R41 |
| metaldehyde | 0.02 | 0.75 | Xn R10 R22 | ||
| metam-sodium | 0.001 | 0.1 | 0.005 | 0.79 | C N R22 R31 R34 R43 R50/53 |
| metamitrone | 0.03 | 0.1 | 0.036 | 22 | N Xn R22 R50 S2 S61 |
| metazachlore | 0.08 | 0.5 | 0.2 | 0.47 | Xi R43 |
| metconazole | 0.01 | 0.01 | 0.01 | 0.291 | N Xn R22 R51/53 R63 S2 S36/37 S46 S61 |
| methamidophos | 0.001 | 0.003 | 0.001 | N T+ R24 R26/28 R50 S1/2 S28 S36/37 S60 S61 | |
| methomyl | 0.0025 | 0.0025 | 0.0025 | N T+ R28 R50/53 S1/2 S28 S36/37 S45 S60 S61 | |
| methoxyfenozide | 0.1 | 0.2 | 0.1 | 7 | N R50/53 S60 S61 |
| metiram-zinc | 0.03 | non pertinente en accord avec le réglement LMR 396/2005 (UE 01/09/2008) | 0.016 | 1.75 | EC |
| metosulam | 0.01 | proposition d' ARFD provisoire : 0.25 mg/kg/j(NOAEL14 j chien, VO/FS 100) UE 01/09/2008 (réglement 396/2005) | 0.01 | 0.079 | N R50/53 R54 |
| metrafenone | 0.25 | non pertinent | 0.43 | 22.5 | N R50/53 S36/37 S60 S61 |
| metribuzine | 0.013 | 0.02 | 0.02 | 0.79 | N Xn R22 R50/53 S2 S60 S61 |
| metsulfuron methyle | 0.22 | non pertinent | 0.7 | 0.036 | N R50/53 S60 S61 |
| milbemectine | 0.03 | 0.03 | 0.014 | 0.012 | N Xn R20/22 R50/53 S2 S46 S60 S61 |
| molinate | 0.008 | 0.1 | 0.008 | 22 | N Xn R20/22 R40 R43 R48/22 R50/53 R63 S2 S36/37 S46 S60 S61 |
| myclobutanil | 0.025 | 0.31 | 0.03 | 2.4 | N Xn R22 R36 R51/53 R63 |
| napropamide | 0.3 | non pertinent, d'apresle RR finalisé | 0.5 | EC | |
| nicosulfuron | 2 | et non pertinent d'après UE 01/09/2008 (réglement 396/2005) | 0.8 | 0.17 | EC R52/53 |
| oryzalin | 0.48 | N Xi R43 R50/53 | |||
| oxadiargyl | 0.008 | non pertinent | 0.006 | 0.23 | N Xn R48/22 R50/53 R63 S2 S36/37 S46 S60 S61 |
| oxadiazon | 0.0036 | non pertinent d'après l'UE 14/03/2008 | 0.18 | 0.75 | N R50/53 S60 S61 |
| oxamyl | 0.001 | 0.001 | 0.001 | 2.68 | N T+ R21 R26/28 R51/53 S1/2 S36/37 S45 S61 |
| oxasulfuron (fiche en cours d'élaboration) | 0.013 | non pertinent | 0.013 | 0.081 | N Xn R48/22 R50/53 S2 S46 S60 S61 |
| oxyfluorfene | 0.003 | 0.2 | 0.032 | N R50/53 S61 | |
| paclobutrazol | 0.022 | 0.1 | 0.82 | Xn R22 R36/38 | |
| penconazole | 0.03 | 0.5 | 0.03 | Xn R48/22 | |
| pencycuron | 0.018 | non pertinent, d'apres la monographie hollandaise | EC | ||
| pendimethaline | 0.125 | non pertinent | 0.234 | 0.55 | N Xi R43 R50/53 S2 S24 S29 S37 S60 S61 |
| penoxsulame (fiche en cours d'élaboration) | 0.05 | non pertinent | 0.18 | 0.33 | EC |
| pethoxamid (fiche en cours d'élaboration) | 0.01 | 0.08 | 0.02 | 0.195 | N Xn R22 R43 R50/53 S2 S24 S37 S46 S60 S61 |
| phenamiphos | 0.0008 | 0.0025 | 0.0008 | N T+ R24 R28 R50/53 S1/2 S23 S28 S36/37 S45 S60 S61 | |
| phenmediphame | 0.03 | non pertinent d'aprèsUE 01/09/2008 (réglement 396/2005) | 0.13 | 4.1 | N R50/53 S60 S61 |
| phosmet | 0.003 | 0.045 | 0.02 | N Xn R21/22 R50/53 S2 S22 S36/37 S60 S61 | |
| phosphate ferrique | 0.8 | non pertinent | AOEL (AJMT) en ion fer: 0.8 mg/kg/j(JECFA, 1983) | 1000 | EC |
| phosphure d'aluminium | 0.019 | 0.032 | 0.019 | F N T+ R15/29 R28 R32 R50 S1/2 S28 S3/9/14 S30 S36/37 S43 S45 S61 | |
| phosphure d'hydrogene | 0.011 | 0.019 | 0.0116 | F+ N T+ R12 R17 R26 R34 R50 S1/2 S28 S36/37 S45 S61 S63 | |
| phosphure de calcium (fiche en cours d'élaboration) | 0.03 | 0.051 | 0.03 | F N T+ R15/29 R28 R50 S1/2 S22 S28 S36/37 S43 S45 S61 | |
| phosphure de magnesium | 0.022 | 0.038 | 0.022 | F N T+ R15/29 R28 R50 S1/2 S22 S28 S43 S45 S61 | |
| piclorame | 0.3 | 0.3 | 0.2 | 5.5 | N R51/53 S61 |
| piclorame : ester isooctylique | se reporter au piclorame | se reporter au piclorame | |||
| piclorame : sel de potassium | se reporter au piclorame | se reporter au piclorame | 5.5 | ||
| piclorame sel d'isopropylamine | se reporter au piclorame | se reporter au piclorame | |||
| picolinafen | 0.014 | 0.05 | 0.03 | 0.036 | N R50/53 S61 |
| picoxystrobine | 0.043 | non pertinent | 0.043 | 5 | N Xn R20 R50/53 S2 S46 S60 S61 |
| pinoxaden (fiche en cours d'élaboration) | 0.1 | 0.1 | 0.1 | 90.86 | Xn R20 R36 R63 | prochloraz | 0.01 | 0.1 | 0.02 | 0.55 | N Xn R22 R50/53 S2 S60 S61 |
| prochloraze manganese | se reporter au prochloraz | se reporter au prochloraz | |||
| prohexadione-calcium | 0.2 | non pertinent | 0.35 | 1000 | EC |
| prometryne | EC | ||||
| propamocarbe | 0.29 | 1 | 0.29 | 630 | Xi R43 |
| propaquizafop | 0.015 | 0.02 | 0.04 | N Xn R48/22 R50/53 | |
| propargite | 0.007 | 0.03 | 0.0225 | N T R23 R38 R40 R41 R50/53 S1/2 S26 S36/37/39 S45 S60 S61 | |
| propiconazol | 0.04 | 0.3 | 0.1 | 5.1 | N Xn R22 R43 R50/53 S2 S36/37 S46 S60 S61 |
| propinebe | 0.007 | 0.1 | 0.003 | 2.6 | N Xn R20 R43 R48/20/22 R50 S1/2 S24 S37 S46 S61 |
| propoxycarbazone sodium | 0.4 | non pertinent | 0.3 | 0.45 | N R50/53 S60 S61 |
| propyzamide | 0.02 | non pertinent | 0.08 | 8.2 | N Xn R40 R50/53 |
| proquinazid | 0.01 | 0.2 | 0.02 | 0.18 | Xn R40 |
| prosulfocarbe | 0.005 | 0.1 | 0.007 | 5 | N Xn R22 R43 R51/53 S24 S37 S61 |
| prosulfuron | 0.02 | non pertinent | 0.06 | 0.126 | N Xn R22 R50/53 S2 S60 S61 |
| prothioconazole | 0.05 | 0.2 | 0.2 | 0.34 | N Xn R51/53 R63 S2 S36/37 S46 S60 S61 |
| PTU (propylènethio urée) (fiche en cours d'élaboration) | 0.0003 | 0.003 | Xn R22 R52/53 R63 | ||
| pymetrozine | 0.03 | 0.1 | 0.03 | 2.5 | Xn R40 R52/53 S2 S36/37 S61 |
| pyraclostrobine | 0.03 | 0.03 | 0.015 | 0.23 | N T R23 R38 R50/53 S1/2 S45 S60 S61 S63 |
| pyraflufen ethyl | 0.2 | 0.2 | 0.112 | 0.0115 | N R50/53 S60 S61 |
| pyridabene | 0.01 | 0.05 | 0.023 | N Xn R20/22 R50/53 | |
| pyridate | 0.036 | non pertinent | 0.036 | 1 | N Xi R38 R43 R50/53 |
| pyrimethanil | 0.17 | non pertinent UE 01/09/2008 (réglement 396/2005) | 0.12 | 29 | N R51/53 S61 |
| pyrimicarbe | 0.035 | 0.1 | 0.035 | 1.7 | N T R25 R50/53 |
| pyriproxyfen | 0.1 | 10 | 0.04 | N R50/53 | |
| pyroxsulame (fiche en cours d'élaboration) | 0.02 | non pertinente en accord avec le réglement LM 396/2005 (01/09/2008) | 0.14 | 0.257 | Xn R40 R43 |
| quinmerac | 0.08 | 0.3 | 0.3 | 316 | Xi R43 |
| quinoclamine | 0.002 | 0.05 | 0.03 | 0.21 | Xn R22 R36 R43 R48/22 R50/53 R63 |
| quinoxyfen | 0.2 | non pertinent | 0.14 | 0.8 | N Xi R43 R50/53 S2 S24 S37 S46 S60 S61 |
| quizalofop-P-ethyl | 0.009 | sinonnon pertinent selon EFSA 2008 | 0.01 | 2.1 | N Xn R22 R50/53 S2 S46 S60 S61 |
| quizalofop-P-tefuryl (fiche en cours d'élaboration) | 0.013 | 0.1 | 0.01 | 2.3 | N T R22 R48/22 R50/53 R61 R62 R68 S45 S53 S60 S61 |
| rimsulfuron | 0.1 | non pertinent | 0.07 | 0.46 | N R50/53 |
| rotenone | 0.001 | 0.00013 | 0.19 | N T R25 R36/37/38 R50/53 | |
| S-metolachlore | 0.1 | non pertinent. | 0.15 | 6.7 | N Xi R43 R50/53 S2 S24 S37 S60 S61 |
| silthiopham | 0.064 | non pertinent | 0.1 | 47 | N R51/53 S37 S60 S61 |
| sintofen | 0.091 | 0.55 | 0.165 | N Xn R40 R51/53 | |
| soufre | 1.5 | non pertinent, | Xi R38 S2 S46 | ||
| spinosad | 0.024 | non pertinent | 0.024 0.012 | 0.17 | N R50/53 S60 S61 |
| spirodiclofen | 0.015 | 1.1 | |||
| spiroxamine | 0.025 | non pertinent | 0.024 | 1.94 | N Xn R20/21/22 R38 R43 R50/53 |
| sulcotrione | 0.0004 | non pertinente d'après l'UE | 0.0006 | Xn R36 R40 R43 | |
| sulfate de fer | Xn R22 R36/38 S2 S46 | ||||
| sulfosate | 0.2 | 0.25 | 0.1 | N Xn R22 R51/53 | |
| sulfosulfuron | 0.24 | non pertinent | 1 | 0.096 | N R50/53 S60 S61 |
| tau-fluvalinate | 0.005 | 0.01 | N Xn R22 R38 R50/53 | ||
| tebuconazole | 0.03 | 0.03 | 0.03 | 1.325 | N Xn R22 R51/53 R63 S2 S22 S36/37 S61 |
| tebufenozide | 0.02 | 0.9 | 0.042 | N R51/53 | |
| tebufenpyrad | 0.02 | 0.02 | Xn R20 R22 R36 R50/53 | ||
| teflubenzuron | 0.01 | non pertinent d'aprèsl'UE | 0.016 | 0.0044 | EC |
| tefluthrine | 0.005 | 0.005 | 0.0014 | 0.0004 | N T R23/24/25 R50/53 S36/37 S45 S60 S61 |
| tembotrione | 0.001 | 0.01 | 0.003 | 0.599 | Xn R43 R48/22 R63 |
| tepraloxydim | 0.025 | 0.4 | 0.06 | 650 | Xn R40 R62 R63 S2 S36/37 S46 |
| terbuthylazine (fiche en cours d'élaboration) | 0.002 | 0.008 | 0.0126 | 4.5 | N Xn R22 R50/53 |
| tetraconazole | 0.005 | 0.2 | 0.03 | 11 | N Xn R20/22 R51/53 S2 S36 S61 |
| thiabendazole | 0.1 | 0.1 | 1.2 | N R50/53 S60 S61 | |
| thiacloprid | 0.01 | 0.03 | 0.02 | 0.32 | N Xn R20/22 R40 R50/53 S2 S36/37 S46 |
| thiamethoxam | 0.026 | 0.5 | 0.08 | 1 | N Xn R22 R50/53 S2 S60 S61 |
| thifensulfuron methyle | 0.01 | non pertinent | 0.07 | 0.13 | N R50/53 S60 S61 |
| thiocyanate d'ammonium (fiche en cours d'élaboration) | 0.8 | N Xn R20/21/22 R32 R50/53 | |||
| thiodicarbe | 0.01 | 0.01 | 0.014 | T R25 R36 | |
| thiophanate-methyl | 0.08 | 0.2 | 0.08 | 10.7 | N Xn R20 R43 R50/53 R68 S2 S36/37 S46 S60 S61 |
| thirame | 0.01 | 0.6 | 0.02 | 1 | N Xn R20/22 R36/38 R43 R48/22 R50/53 S2 S26 S36/37 S60 S61 |
| tolclophos methyle | 0.064 | non pertinent | 0.2 | 1.2 | N Xi R43 R50/53 S2 S24 S37 S60 S61 |
| tolylfluanide | 0.1 | 0.25 | 0.3 | 14.7 | N T+ R26 R36/37/38 R43 R48/23 R50 S1/2 S28 S36/37/39 S45 S61 S63 |
| tralkoxydime | 0.005 | 0.01 | 0.005 | Xn R22 R36 | |
| triadimenol | 0.03 | 0.08 | 0.05 | Xn R22 | |
| triallate | 0.025 | 0.006 | N Xn R22 R43 R48/22 R50/53 | ||
| triasulfuron | 0.01 | non pertinent | 0.3 | 0.0068 | N R50 R53 |
| tribenuron-methyle | 0.01 | 0.2 | 0.07 | 0.43 | N Xi R43 R50/53 S2 S24 S37 S46 S60 S61 |
| triclopyr | 0.03 | 0.3 | 0.05 | 5.8 | Xn R22 R36 R43 S2 S36/37 S46 |
| triclopyr : sel de triethylamine | se reporter au triclopyr | se reporter au triclopyr | se reporter au triclopyr | ||
| triclopyr butoxy ethyl ester | se reporter au triclopyr (acide) | se reporter au triclopyr (acide) | 0.05 | 3.1 | Xn R22 R36 R43 S2 S36/37 S46 |
| trifloxystrobine | 0.1 | non pertinent | 0.06 | 1.2 | N Xi R43 R50/53 S2 S24 S37 S46 S60 S61 |
| trifluraline (fiche en cours d'élaboration) | 0.015 | non pertinent | 0.2 | N Xn R40 R43 R50/53 S2 S36/37 S46 S60 S61 | |
| triflusulfuron-methyle | 0.04 | 1.2 | 0.04 | 0.215 | N Xn R40 R50/53 S2 S36/37 S46 S60 S61 |
| trinexapac-ethyl | 0.32 | non pertinent. | 0.34 | EC | |
| triticonazole | 0.025 | 0.05 | 0.025 | 1 | N R51/53 S61 |
| tritosulfuron | 0.06 | 0.15 | 2.55 | N Xi R43 R50/53 S2 S24 S37 S46 S60 S61 | |
| valiphenal | 0.07 | non pertinente | 0.07 | 28 | N R51/53 |
| vinclozoline (fiche en cours d'élaboration) | 0.005 | 0.06 | 0.02 | N T R40 R43 R51/53 R60 R61 S45 S53 S61 | |
| warfarine | non pertinent car absence de résidus dans la chaine alimentaire. (source UE, 23/09/2005) | non pertinent. (source UE, 23/09/2005) | 0.0002 | T R48/25 R52/53 R61 S45 S53 S61 | |
| zetacypermethrine | 0.04 | 0.125 | 0.02 | 1.3e-005 | N T R23 R25 R43 R50/53 |
| zirame | 0.006 | 0.08 | 0.015 | 18.9 | N T+ R22 R26 R37 R41 R43 R48/22 R50/53 S1/2 S22 S26 S28 S36/37/39 S45 S60 S61 |
| zoxamide | 0.5 | non pertinent. | 0.3 | 0.348 | N Xi R43 R50/53 S2 S24 S37 S46 S60 S61 |
| Substance | DJA (mg/kg/j) | ARfD (mg/kg/j) | AOEL (mg/kg/j) | PNEC (µg/L) | Classement |